Summary
Dr Nathan Bartlett is an Honorary Senior Lecturer in Respiratory Medicine within the Respiratory Infections section, National Heart and Lung Institute (NHLI), Imperial College London. He is currently based at the University of Newcastle, Australia where he is currently building collaborative research programs with asthma researchers in Australia.
Following his award of PhD, Dr Bartlett undertook a 5 year postdoctoral research position with Professor Geoffrey Smith - first at the Sir William Dunn School of Pathology, University of Oxford, then in the Department of Virology, Imperial College London. Dr Bartlett then undertook a postdoctoral position in the Department of Respiratory Medicine within the NHLI also at Imperial.
Since joining the NHLI, Dr Bartlett has investigated the interaction of viral infection with type immunity to uncover pathogenic mechanisms in asthma exacerbations. He is a co-applicant on several successful project and program grants and since his lecturer appointment was successful as a Principal Investigator in achieving an MRC project grant to study the role of IL-25 in asthma exacerbations which was recently published as featured cover story in Science Translational Medicine (October 2014). He has authored three Nature Medicine papers including Bartlett et al, Nat Med 2008, the world's first mouse rhinovirus infection model which received extensive media coverage (TV, radio and newspaper). Dr Bartlett was interviewed on radio by BBC World and ABC Canberra, Australia and has been highlighted by Asthma UK as an important researcher in their magazine. Dr Bartlett has contributed to several scholarly books including the Rhinovirus chapter for the Encyclopaedia of Virology (Elsevier).
Publications
Journals
Chairakaki A-D, Saridaki M-I, Pyrillou K, et al., 2018, Plasmacytoid dendritic cells drive acute exacerbations of asthma, Journal of Allergy and Clinical Immunology, Vol:142, ISSN:0091-6749, Pages:542-556.e12
Reid AT, Veerati PC, Gosens R, et al., 2018, Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches, Pharmacology & Therapeutics, Vol:185, ISSN:0163-7258, Pages:155-169
Wark PAB, Ramsahai JM, Pathinayake P, et al., 2018, Respiratory Viruses and Asthma., Semin Respir Crit Care Med, Vol:39, Pages:45-55
Toussaint M, Jackson DJ, Swieboda D, et al., 2017, Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation, Nature Medicine, Vol:23, ISSN:1078-8956, Pages:681-691
Tunstall T, Kon OM, Bartlett N, et al., 2017, A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13), Ebiomedicine, Vol:19, ISSN:2352-3964, Pages:128-138